GLMD — Galmed Pharmaceuticals Ltd.
Fresh Supply424B filed ~44d ago🖨 Heavy Printer🌀 Serial Splitter📄 Fresh Paper1-for-158 cumulative
XBRL EDGAR
424B filed ~44d ago
Case Notes
Galmed Pharmaceuticals Ltd. has 3 reverse splits on record — cumulative 1-for-158. Its share count grew 297.8% over the last twelve months per XBRL EDGAR data.
No stress-language filings on record in our dataset. However, 2 supply registrations (S-1/424B) appear in the last 12 months.
Registered shares exist to be sold — that is what the S-1 and 424B instruments document. In our research across this filing posture, freshly registered supply is the loaded state of the cycle: the paperwork has created the legal right to place shares into the market. That is not a prediction — it is what the filings say is possible.
Share Count Over Time
XBRL cover-page share counts from SEC EDGAR filings. Amber dashed lines mark reverse-split dates. 3 reverse splits on record.
Reverse Split Log
Each event consolidates shares — fewer shares, same market cap. Source: EDGAR corporate actions.
Cumulative effective ratio: 1-for-158— a share held at inception is now worth 1/158 of its original fraction.
424B Supply Pulse
Prospectus supplements (424B5) filed registering shares for resale — each bar is one month with a filing. Bars above average signal active distribution windows. Source: SEC EDGAR.